Candidate biomarkers in psychiatric disorders: state of the field
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can
aid in objectively diagnosing patients and providing individualized treatment …
aid in objectively diagnosing patients and providing individualized treatment …
New and emerging approaches to treat psychiatric disorders
Psychiatric disorders are highly prevalent, often devastating diseases that negatively impact
the lives of millions of people worldwide. Although their etiological and diagnostic …
the lives of millions of people worldwide. Although their etiological and diagnostic …
[HTML][HTML] Advances in problematic usage of the internet research–A narrative review by experts from the European network for problematic usage of the internet
NA Fineberg, JM Menchón, N Hall, B Dell'Osso… - Comprehensive …, 2022 - Elsevier
Global concern about problematic usage of the internet (PUI), and its public health and
societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 …
societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 …
Treatment of anxiety disorders
B Bandelow, S Michaelis… - Dialogues in clinical …, 2017 - Taylor & Francis
Anxiety disorders (generalized anxiety disorder, panic disorder/agoraphobia, social anxiety
disorder, and others) are the most prevalent psychiatric disorders, and are associated with a …
disorder, and others) are the most prevalent psychiatric disorders, and are associated with a …
Psycho-neuroendocrine-immune interactions in COVID-19: potential impacts on mental health
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the …
Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the …
[HTML][HTML] The diagnosis and treatment of anxiety disorders
A Ströhle, J Gensichen, K Domschke - Deutsches Ärzteblatt …, 2018 - ncbi.nlm.nih.gov
Background Anxiety disorders are the most common type of mental illness in Europe, with a
12-month prevalence of 14% among persons aged 14 to 65. Their onset is usually in …
12-month prevalence of 14% among persons aged 14 to 65. Their onset is usually in …
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version …
Aim This is the third version of the guideline of the World Federation of Societies of
Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety …
Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety …
[HTML][HTML] Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Current medication for anxiety disorders is suboptimal in terms of efficiency and tolerability,
highlighting the need for improved drug treatments. In this review an overview of drugs …
highlighting the need for improved drug treatments. In this review an overview of drugs …
Anxiety disorders: a review of current literature
F Thibaut - Dialogues in clinical neuroscience, 2017 - Taylor & Francis
Anxiety disorders are the most prevalent psychiatric disorders. There is a high comorbidity
between anxiety (especially generalized anxiety disorders or panic disorders) and …
between anxiety (especially generalized anxiety disorders or panic disorders) and …
Childhood trauma in schizophrenia: current findings and research perspectives
Schizophrenia is a severe neuropsychiatric disorder with persistence of symptoms
throughout adult life in most of the affected patients. This unfavorable course is associated …
throughout adult life in most of the affected patients. This unfavorable course is associated …